Zentiva, a leading pharmaceutical company headquartered in the Czech Republic (CZ), has established itself as a key player in the generic and specialty medicines sector since its founding in 2003. With a strong presence across Europe, Zentiva focuses on delivering high-quality, affordable healthcare solutions that cater to diverse patient needs.
The company’s core offerings include a wide range of generic medications, over-the-counter products, and specialty pharmaceuticals, all designed to enhance patient access to essential treatments. Zentiva is recognised for its commitment to quality and innovation, ensuring that its products meet rigorous industry standards.
Notable achievements include expanding its operational footprint in major European markets, positioning Zentiva as a trusted partner in healthcare. With a dedication to sustainability and patient-centric solutions, Zentiva continues to make significant strides in the pharmaceutical industry.
+37 vs industry average
Zentiva’s score of 75 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Zentiva?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Zentiva's reported carbon emissions
In 2024, Zentiva reported total carbon emissions of approximately 411.9 million kg CO2e. This figure includes Scope 1 emissions of about 13.7 million kg CO2e, Scope 2 emissions of approximately 14.1 million kg CO2e (market-based), and a significant contribution from Scope 3 emissions, which totalled around 384.1 million kg CO2e. The Scope 3 emissions breakdown includes major categories such as purchased goods and services (approximately 308.1 million kg CO2e) and upstream transportation and distribution (about 19.3 million kg CO2e). In comparison, the previous year, 2023, saw total emissions of approximately 81.4 million kg CO2e, with Scope 1 at about 15.0 million kg CO2e, Scope 2 at approximately 13.6 million kg CO2e, and Scope 3 emissions reaching around 53.0 million kg CO2e. This indicates a substantial increase in emissions in 2024. Zentiva's emissions data is cascaded from its parent company, Sanofi, reflecting a corporate family relationship. However, there are currently no specific reduction targets or climate pledges disclosed by Zentiva, indicating a potential area for future commitment in line with industry standards. The company is positioned within the pharmaceutical sector, which is increasingly focusing on sustainability and carbon reduction initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Zentiva’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Zentiva yet.
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project